V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220006827 | 220002626 | 1.58 | 60 | Palliative (P) | 2016-07-07 | 2016-07-07 | Carboplatin + Paclitaxel (3 weekly) | N | N | 220031131 | CARBOPLATIN + PACLITAXEL |
| 220006828 | 220002627 | null | 54.2 | null | 2016-01-23 | 2016-02-01 | GemCarbo Days 1+8 | N | N | 220031135 | GEMCARBO |
| 220006829 | 220002628 | 1.6 | 74.8 | Curative (C) | 2017-02-21 | 2017-02-21 | AML18 PILOT TRIAL | Y | N | 220031137 | PILOT TRIAL |
| 220006830 | 220011524 | null | 81.6 | Curative (C) | 2016-08-11 | 2016-08-16 | AML18 PILOT TRIAL | N | N | 220031139 | PILOT TRIAL |
| 220006831 | 220011524 | 1.7 | 87.8 | Curative (C) | 2017-05-21 | 2017-05-21 | AML16 DA 3+10 | N | N | 220031139 | AML16 TRIAL |
| 220006836 | 220002630 | 1.73 | 102.5 | Palliative (P) | 2013-11-04 | 2013-11-04 | Cisplatin + Gemcitabine (D 1 & 8) | N | null | 220031155 | CISPLATIN + GEMCITABINE |
| 220006837 | 220002631 | 1.63 | 100 | null | 2015-01-06 | 2015-01-06 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | 220031157 | CISPLATIN + GEMCITABINE |
| 220006838 | 220011526 | 1.56 | 58.7 | Curative (C) | 2013-02-04 | 2013-02-09 | AML16 DA 3+10 | N | null | 220031158 | AML16 TRIAL |
| 220006839 | 220016199 | 1.7 | 55 | Curative (C) | 2016-06-14 | 2016-06-14 | AML18 PILOT TRIAL | null | N | 220031163 | PILOT TRIAL |
| 220006840 | 220002632 | 1.79 | 74.8 | Palliative (P) | 2017-06-14 | 2017-06-14 | IDARUBICIN + TRETINOIN | N | N | 220031164 | IDARUBICIN + TRETINOIN |
| 220006841 | 220002633 | 1.84 | 63.8 | Curative (C) | 2015-11-15 | 2015-11-20 | AML16 DA 3+10 | null | N | 220031166 | AML16 TRIAL |
| 220006842 | 220002633 | 1.7 | 67.3 | Palliative (P) | 2016-05-28 | 2016-07-03 | AML16 DA 3+10 | Y | N | 220031166 | AML16 TRIAL |
| 220006843 | 220002633 | 1.54 | 56.9 | Palliative (P) | 2017-05-02 | 2017-05-07 | Cisplatin + Gemcitabine (D 1 & 8) | 2 | N | 220031166 | CISPLATIN + GEMCITABINE |
| 220006847 | 220002635 | 1.7 | 76 | Palliative (P) | 2013-04-27 | 2013-05-02 | Carboplatin + Paclitaxel (3 weekly) | null | N | 220031179 | CARBOPLATIN + PACLITAXEL |
| 220006848 | 220002636 | null | -1 | Palliative (P) | 2014-12-04 | 2014-12-11 | Dasatinib | 99 | N | 220031180 | DASATINIB |
| 220006849 | 220002637 | 1.58 | 47.5 | Palliative (P) | 2013-04-07 | 2013-04-07 | CARBOPLATIN + PACLITAXEL | 02 | N | 220031181 | CARBOPLATIN + PACLITAXEL |
| 220006850 | 220002638 | 1.66 | 88.2 | Curative (C) | 2013-10-21 | 2013-10-26 | AML16 DA 3+10 | N | N | 220031184 | AML16 TRIAL |
| 220006851 | 220002638 | 1.59 | 45.2 | Curative (C) | 2013-12-15 | 2013-12-15 | IDARUBICIN + TRETINOIN | null | N | 220031184 | IDARUBICIN + TRETINOIN |
| 220006852 | 220002639 | 1.55 | 81.3 | Curative (C) | 2013-06-07 | 2013-06-16 | AML 18 Pilot Trial | Y | N | 220031188 | PILOT TRIAL |
| 220006853 | 220011530 | null | 105.4 | Curative (C) | 2015-01-09 | 2015-01-09 | Dasatinib | 02 | N | 220031190 | DASATINIB |
| 220006854 | 220011530 | 1.79 | null | Palliative (P) | null | 2015-04-09 | GemCarbo Days 1+8 | N | N | 220031190 | GEMCARBO |
| 220006855 | 220002640 | 1.65 | 58.7 | Curative (C) | 2016-06-13 | 2016-06-13 | AML 18 Pilot Trial | Y | N | 220031193 | PILOT TRIAL |
| 220006856 | 220002641 | 1.85 | null | Palliative (P) | 2016-04-01 | 2016-05-04 | AML16 Low Dose Cytarabine | N | N | 220031195 | AML16 TRIAL |
| 220006857 | 220002642 | 1.7 | 82.1 | Palliative (P) | null | 2015-08-16 | GemCarbo Days 1+8 | N | N | 220031196 | GEMCARBO |
| 220006859 | 220002644 | 1.77 | 79.6 | Palliative (P) | 2016-04-13 | 2016-04-21 | Dasatinib | N | N | 220031200 | DASATINIB |
| 220006862 | 220002647 | 1.6 | 58 | Palliative (P) | 2014-03-20 | 2014-03-20 | GemCarbo Days 1+8 | N | N | 220031204 | GEMCARBO |
| 220006863 | 220002648 | 1.5 | 69.6 | Curative (C) | 2015-07-01 | 2015-07-01 | AML 18 Pilot Trial | Y | N | 220031205 | PILOT TRIAL |
| 220006864 | 220002648 | 1.6 | 105 | Palliative (P) | 2017-05-24 | 2017-06-06 | Dasatinib | 2 | N | 220031205 | DASATINIB |
| 220006865 | 220002649 | 0 | 69.6 | Palliative (P) | 2015-01-06 | 2015-02-02 | CISPLATIN + GEMCITABINE | N | N | 220031209 | CISPLATIN + GEMCITABINE |
| 220006867 | 220011532 | 1.76 | null | Neo-adjuvant (N) | 2016-07-23 | 2016-07-24 | AML 18 TRIAL | 01 | N | 220031213 | AML18 TRIAL |
| 220006868 | 220011532 | 1.55 | 55.5 | Palliative (P) | 2015-05-02 | 2015-05-12 | Carboplatin + Paclitaxel (3 weekly) | N | N | 220031213 | CARBOPLATIN + PACLITAXEL |
| 220006869 | 220002651 | null | 79.4 | Curative (C) | null | 2017-07-28 | AML 18 TRIAL | 01 | N | 220031215 | AML18 TRIAL |
| 220006870 | 220002652 | 1.52 | 60 | Palliative (P) | 2016-08-02 | 2016-08-17 | Cisplatin + Gemcitabine (D 1 & 8) | null | N | 220031217 | CISPLATIN + GEMCITABINE |
| 220006871 | 220002653 | 1.57 | 56 | null | 2013-11-20 | 2014-01-17 | Cisplatin+Gemcitabine (gallbladder) | null | N | 220031219 | CISPLATIN + GEMCITABINE |
| 220006872 | 220002653 | 1.78 | 60.3 | Palliative (P) | 2017-05-04 | 2017-05-15 | Carboplatin + Paclitaxel (3 weekly) | N | N | 220031219 | CARBOPLATIN + PACLITAXEL |
| 220006873 | 220002653 | null | 62 | Curative (C) | 2015-08-03 | 2015-09-04 | AML16 DA 3+10 | Y | N | 220031219 | AML16 TRIAL |
| 220006874 | 220002654 | 1.51 | 57 | Curative (C) | 2013-08-11 | 2013-08-11 | Carboplatin + Paclitaxel (3 weekly) | N | N | 220031222 | CARBOPLATIN + PACLITAXEL |
| 220006875 | 220002654 | 1.6 | 63.2 | null | 2017-04-27 | 2017-05-08 | IDARUBICIN + TRETINOIN | null | null | 220031222 | IDARUBICIN + TRETINOIN |
| 220006876 | 220002655 | null | 64 | Palliative (P) | 2016-04-07 | 2016-04-10 | GemCarbo Days 1+8 | N | N | 220031225 | GEMCARBO |
| 220006877 | 220002656 | 1.6 | 48.9 | Palliative (P) | 2017-06-11 | 2017-06-17 | Cisplatin+Gemcitabine (gallbladder) | 02 | N | 220031227 | CISPLATIN + GEMCITABINE |
| 220006878 | 220002657 | 1.75 | 61.3 | null | 2016-01-26 | 2016-02-09 | IDARUBICIN + TRETINOIN | 02 | N | 220031228 | IDARUBICIN + TRETINOIN |
| 220006879 | 220002657 | null | 100.7 | Curative (C) | null | 2017-03-11 | AML 18 TRIAL | Y | N | 220031228 | AML18 TRIAL |
| 220006880 | 220002657 | 1.76 | 78 | Curative (C) | 2016-12-24 | 2017-01-30 | AML16 DA 3+10 | N | N | 220031228 | AML16 TRIAL |
| 220006881 | 220002658 | 1.82 | 58 | Palliative (P) | 2016-11-19 | 2016-11-26 | AML16 DA 3+10 | Y | N | 220031232 | AML16 TRIAL |
| 220006883 | 220002660 | 1.79 | 91.4 | Curative (C) | null | 2013-11-12 | AML16 DA 3+10 | Y | N | 220031235 | AML16 TRIAL |
| 220006884 | 220002660 | 1.67 | 75.2 | Palliative (P) | 2016-06-13 | 2016-07-01 | GemCarbo Days 1+8 | 2 | N | 220031235 | GEMCARBO |
| 220006885 | 220016206 | 1.88 | 95.6 | Curative (C) | 2015-07-15 | 2015-07-21 | AML18 PILOT TRIAL | Y | N | 220031242 | PILOT TRIAL |
| 220006886 | 220002661 | 1.72 | 92.1 | Palliative (P) | 2017-03-09 | 2017-03-09 | Carboplatin + Paclitaxel (weekly) | null | N | 220031245 | CARBOPLATIN + PACLITAXEL |
| 220006893 | 220022008 | 1.63 | 85.4 | Curative (C) | null | 2014-02-10 | AML 18 TRIAL | 1 | N | 220031257 | AML18 TRIAL |
| 220006894 | 220002662 | 1.72 | 64.5 | Curative (C) | null | 2014-04-28 | IDARUBICIN + TRETINOIN | N | null | 220031258 | IDARUBICIN + TRETINOIN |